HLscience Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 28.60%

HLscience Co. Ltd (239610) has an Asset Resilience Ratio of 28.60% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 239610 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩25.60 Billion
≈ $17.35 Million USD Cash + Short-term Investments

Total Assets

₩89.51 Billion
≈ $60.66 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how HLscience Co. Ltd's Asset Resilience Ratio has changed over time. See 239610 net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down HLscience Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see HLscience Co. Ltd (239610) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩25.60 Billion 28.6%
Total Liquid Assets ₩25.60 Billion 28.60%

Asset Resilience Insights

  • Very High Liquidity: HLscience Co. Ltd maintains exceptional liquid asset reserves at 28.60% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

HLscience Co. Ltd Industry Peers by Asset Resilience Ratio

Compare HLscience Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Yabao Pharmaceutical Group Co Ltd
SHG:600351
Drug Manufacturers - Specialty & Generic 0.27%
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
Drug Manufacturers - Specialty & Generic 0.16%
Sandoz Group AG
SW:SDZ
Drug Manufacturers - Specialty & Generic 6.43%
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 6.40%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%

Annual Asset Resilience Ratio for HLscience Co. Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for HLscience Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 10.88% ₩10.64 Billion
≈ $7.21 Million
₩97.78 Billion
≈ $66.26 Million
-13.94pp
2023-12-31 24.82% ₩26.30 Billion
≈ $17.82 Million
₩105.97 Billion
≈ $71.81 Million
-2.14pp
2022-12-31 26.96% ₩29.34 Billion
≈ $19.88 Million
₩108.82 Billion
≈ $73.74 Million
-21.85pp
2021-12-31 48.81% ₩57.53 Billion
≈ $38.99 Million
₩117.87 Billion
≈ $79.88 Million
-12.71pp
2020-12-31 61.52% ₩65.86 Billion
≈ $44.64 Million
₩107.06 Billion
≈ $72.55 Million
-1.58pp
2019-12-31 63.10% ₩59.58 Billion
≈ $40.38 Million
₩94.42 Billion
≈ $63.99 Million
-2.63pp
2018-12-31 65.74% ₩46.94 Billion
≈ $31.81 Million
₩71.41 Billion
≈ $48.39 Million
+4.59pp
2017-12-31 61.15% ₩35.30 Billion
≈ $23.93 Million
₩57.74 Billion
≈ $39.13 Million
-6.84pp
2016-12-31 67.99% ₩37.11 Billion
≈ $25.15 Million
₩54.58 Billion
≈ $36.99 Million
+51.26pp
2015-12-31 16.73% ₩2.91 Billion
≈ $1.97 Million
₩17.39 Billion
≈ $11.79 Million
+7.66pp
2014-12-31 9.07% ₩1.26 Billion
≈ $853.88K
₩13.89 Billion
≈ $9.41 Million
--
pp = percentage points

About HLscience Co. Ltd

KQ:239610 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$30.55 Million
₩45.07 Billion KRW
Market Cap Rank
#23645 Global
#1697 in Korea
Share Price
₩8850.00
Change (1 day)
-0.90%
52-Week Range
₩7080.00 - ₩12720.00
All Time High
₩105342.87
About

HLscience Co., Ltd. manufactures and sells health functional foods in South Korea. The company offers organic barley grassjuice powder one day, queen's pomegranate jin, Super LuzieA+ Astaxanthin, Dr. Superkhan, HL-JOINT 100 for Joint & Cartilage Premium, Dr. Green Propolis, morosil diet fit, skin master secret, enerlinger vitamin D, PS300 formulated by doctor, Skin Master P-estro, and Dr. Prebiot… Read more